Market Overview

BioTelemetry Q4 Earnings Preview


On Thursday, BioTelemetry (NASDAQ: BEAT) will release its latest earnings report. Here is Benzinga's outlook for the company.

Earnings and Revenue

Based on BioTelemetry management projections, analysts predict EPS of 24 cents per share on revenue of $88.3 million.

BioTelemetry EPS in the same period a year ago totaled 23 cents. Revenue was $53.9 million. The analyst consensus estimate would represent a 4.35 percent increase in the company's earnings. Sales would be up 63.65 percent from the same quarter last year.

BioTelemetry's reported EPS has stacked up against analyst estimates in the past like this:


Quarter Q3 2017 Q2 2017 Q1 2017 Q4 2016
EPS Estimate 0.26 0.21 0.16 0.18
EPS Actual 0.16 0.23 0.16 0.23

Stock Performance

Over the last 52-week period, shares are up 32.46 percent. Given that these returns are generally positive, long-term shareholders can be satisfied going into this earnings release. Over the past 90 days, analysts' have generally adjusted their estimates higher for EPS and revenues.

Analysts have been rating BioTelemetry stock as Neutral. The strength of this rating has risen over the past three months.

Conference Call

Don't be surprised to see the stock move on comments made during its conference call. BioTelemetry's Q4 conference call is scheduled to begin at 5:00 p.m. ET and can be accessed here.

Posted-In: Earnings News Previews Trading Ideas


Related Articles (BEAT)

View Comments and Join the Discussion!

This Day In Market History: Warren Buffett Enters The Insurance Business

Mid-Morning Market Update: Markets Open Higher; PPL Profit Tops Expectations